Valeant Pharmaceuticals (VRX) Stock: Declines on CEO Troubles

By |December 28th, 2015|

Valeant Pharmaceuticals Intl Inc (NYSE: VRX)

Valeant Pharmaceuticals has been on a bit of a roller coaster ride in the market as of late, and unfortunately, the roller coaster is currently pointing downward. After confirmation that J. Michael Pearson, the CEO and Chairman of the board at VRX is currently on medical leave, the stock […]